Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
310
result was found. Results that relate to
Drug
Analysis of adverse drug reactions of ustekinumab reported in literature
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(12):1441-1448.
1154 times
271 times
WEI Luman
PENG Haoshuai
YANG Qingyu
PENG Dunquan
LI Xiao
QIAO Yi
Ustekinumab
Adverse
drug
reactions
Case report
Literature analysis
Details
Pharmaceutical care for a pediatric patient with relapsed/refractory Burkitt lymphoma treated with glofitamab
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(12):1457-1462.
1203 times
281 times
LI Huiling
WANG Zhuowei
YU Liting
Relapsed/refractory Burkitt lymphoma
Children
Glofitamab
Adverse
drug
reaction
Pharmaceutical care
Details
A case of anaphylactic shock caused by lauromacrogol injection
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(12):1463-1467.
1100 times
274 times
LI Doudou
XU Baoping
YANG Hao
LIU Jin
Lauromacrogol injection
Anaphylactic shock
Esophagogastric variceal bleeding
Adverse
drug
reaction
Details
A case of upper gastrointestinal bleeding caused by atezolizumab
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(12):1468-1472.
1133 times
267 times
LIU Xinmiao
TONG Jingjing
Atezolizumab
Upper gastrointestinal bleeding
Immune checkpoint inhibitors
Adverse
drug
reactions
Details
Analysis of influencing factors and predictive model construction of anti-tuberculosis drug-induced liver injury
Published on
New Medicine
2025,35(12):1413-1420.
3128 times
327 times
GU Zhengtai
LIU Weiwei
GU Lingyun
MA Chenbin
Tuberculosis
Anti-tuberculosis
drug
-induced liver injury
Influencing factors
Nomogram
Details
Analysis of key genes for gemcitabine resistance and their pan-cancer expression, immune infiltration and survival associations
Published on
Journal of Mathematical Medicine
2025,38(12):936-948.
999 times
246 times
SHEN Ruibo
YANG Yulin
ZHANG Xin
LIANG Xinyi
YANG Huan
DU Juan
Gemcitabine
Drug
resistance
Key genes
Pan-cancer
Immune infiltration
Survival associations
Details
Signal mining and sex-specific subgroup analysis of donepezil-associated adverse events based on the FAERS database
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(1):51-61.
1196 times
294 times
NING Siming
SUN Bao
ZOU Hao
QI Fengyu
YANG Ruixia
QIAO Yi
Donepezil
FAERS database
Adverse
drug
event
Signal mining
Details
Construction of a shortage risk early warning model based on risk matrix evaluation and Bayesian belief propagation neural network
Published on
Frontiers in Pharmaceutical Sciences
2025,29(12):2027-2035.
1225 times
222 times
SUN Yiyuan
LIU Junjiao
NI Ying
LIANG Liangliang
LIU Yunmei
ZHAO Guohong
ZHANG Jingbo
YANG Yang
LI Qiang
Drug
shortage
Drug
use monitoring
Risk warning
Signal detection
Bayesian confidence propagation neural network
Details
Effective analysis of adverse drug events and toxicological mechanisms of octreotide based on the FAERS database and network toxicology
Published on
Frontiers in Pharmaceutical Sciences
2025,29(12):2036-2045.
1268 times
227 times
WANG Changwen
WANG Huiru
XU Shibo
SUN Fanfan
YAN Junzhen
Octreotide
Adverse
drug
events
Network toxicology
Signal mining
FAERS
Tumor necrosis factor
Ransforming growth factor β
Protein-protein interaction
Details
Pharmacovigilance analysis of drug-related extrapyramidal symptoms based on the FAERS database
Published on
Frontiers in Pharmaceutical Sciences
2025,29(12):2056-2064.
1192 times
222 times
WU Lihua
WANG Huiying
CHEN Yangyi
PAN Lu
RAO Mei
Drug
related extrapyramidal symptoms
Adverse
drug
reactions
Pharmacovigilance
Signal Mining
FAERS database
Logistic regression
Details
Analysis of the impact of international research on dose rounding of anti-tumor drugs on the cost of anti-tumor drugs in China
Published on
Frontiers in Pharmaceutical Sciences
2025,29(12):2065-2071.
1301 times
230 times
REN Lingzhi
YU Wenhao
WANG Ting
TANG Min
ZHOU Ziyuan
TANG Haochun
MENG Jun
Anti-tumor
drug
s
Dose rounding
Drug
cost
Cost saving
Healthcare expenses
Economic burden
Monoclonal antibody
Details
Artificial intelligence reshapes hospital pharmacy practice: advances in application and real-world challenges
Published on
Frontiers in Pharmaceutical Sciences
2025,29(12):2080-2087.
1951 times
298 times
FANG Haiyan
HE Qing
Artificial intelligence
Hospital pharmacy
Machine learning
Natural language processing
Deep learning
Big data
Rational use of
drug
Drug
administration
Details
Research on quality management, responsibilities and regulatory measures of the domestic responsible person for drugs
Published on
Frontiers in Pharmaceutical Sciences
2025,29(12):2088-2097.
1267 times
190 times
WANG Ying
WANG Guangping
Imported
drug
s
Domestic responsible entity
Overseas marketing authorization holders
Quality management responsibility
Responsible entity
Obligation
Challenge
Supervision
Details
Research progress on the chemical constituents and pharmacological effects of Chinese yam
Published on
Frontiers in Pharmaceutical Sciences
2025,29(12):2098-2111.
1605 times
244 times
ZHENG Xiaonan
SUN Cuige
DI Qing
HU Liping
ZHAO Xiangxuan
Chinese yam
Chemical composition
Pharmacological effects
Chronic atrophic gastritis
Drug
target
Network pharmacology
Targeted
drug
s
Natural products
Details
Application of hot stage polarizing microscope in the study of drug polymorphism
Published on
Frontiers in Pharmaceutical Sciences
2025,29(12):2154-2160.
1101 times
209 times
CHEN Hui
WANG Huijie
ZHANG Shibo
LI Yao
WANG Huan
ZHOU Hao
Hot stage polarizing microscope
Drug
polymorphism
Characterization of polymorphism
Control of polymorphism
In-situ research
Crystal habit analysis
Phase transition kinetics
Process optimization
Details
上一页
1
2
12
13
14
15
16
17
18
19
20
21
下一页